Nanotechnology Commercialization for Managers and Scientists

Nanotechnology Commercialization for Managers and Scientists

by Wim Helwegen, Luca Escoffier
Released February 2012
Publisher(s): Jenny Stanford Publishing
ISBN: 9789814364386

Read it now on the O’Reilly learning platform with a 10-day free trial.

O’Reilly members get unlimited access to books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.

Start your free trial

Book description

This book discusses the most relevant issues that a company or university will face when bringing a nanotechnology invention to the market. It discusses obtaining, strategic use, valuation, and licensing of patents. It also deals with venture capital, university-industry collaboration, environmental health and safety, and public perception. The book provides managers and scientists at universities and companies with industry-specific basic knowledge of often unfamiliar issues that are essential to the commercial success of their inventions.

Table of contents

  1. Contents (1/3)
  2. Contents (2/3)
  3. Contents (3/3)
  4. Contributors (1/2)
  5. Contributors (2/2)
  6. Foreword
  7. Preface
  8. 1. Introduction to the World of Nanotechnology (1/7)
  9. 1. Introduction to the World of Nanotechnology (2/7)
  10. 1. Introduction to the World of Nanotechnology (3/7)
  11. 1. Introduction to the World of Nanotechnology (4/7)
  12. 1. Introduction to the World of Nanotechnology (5/7)
  13. 1. Introduction to the World of Nanotechnology (6/7)
  14. 1. Introduction to the World of Nanotechnology (7/7)
  15. 2. Overview of Intellectual Property Rights (1/4)
  16. 2. Overview of Intellectual Property Rights (2/4)
  17. 2. Overview of Intellectual Property Rights (3/4)
  18. 2. Overview of Intellectual Property Rights (4/4)
  19. 3. Nanotechnology Patent Procurement and Litigation in Europe (1/6)
  20. 3. Nanotechnology Patent Procurement and Litigation in Europe (2/6)
  21. 3. Nanotechnology Patent Procurement and Litigation in Europe (3/6)
  22. 3. Nanotechnology Patent Procurement and Litigation in Europe (4/6)
  23. 3. Nanotechnology Patent Procurement and Litigation in Europe (5/6)
  24. 3. Nanotechnology Patent Procurement and Litigation in Europe (6/6)
  25. 4. Nanotechnology Patent Procurement and Litigation in the United States (1/6)
  26. 4. Nanotechnology Patent Procurement and Litigation in the United States (2/6)
  27. 4. Nanotechnology Patent Procurement and Litigation in the United States (3/6)
  28. 4. Nanotechnology Patent Procurement and Litigation in the United States (4/6)
  29. 4. Nanotechnology Patent Procurement and Litigation in the United States (5/6)
  30. 4. Nanotechnology Patent Procurement and Litigation in the United States (6/6)
  31. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (1/6)
  32. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (2/6)
  33. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (3/6)
  34. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (4/6)
  35. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (5/6)
  36. 5. How to Set Up an Effective IP Strategy and Manage a Nanotechnology-Based Patent Portfolio (6/6)
  37. 6. How to Identify Patent Infringements in the Nanotechnology Sector (1/6)
  38. 6. How to Identify Patent Infringements in the Nanotechnology Sector (2/6)
  39. 6. How to Identify Patent Infringements in the Nanotechnology Sector (3/6)
  40. 6. How to Identify Patent Infringements in the Nanotechnology Sector (4/6)
  41. 6. How to Identify Patent Infringements in the Nanotechnology Sector (5/6)
  42. 6. How to Identify Patent Infringements in the Nanotechnology Sector (6/6)
  43. 7. Licensing Issues in Nanotechnology (1/6)
  44. 7. Licensing Issues in Nanotechnology (2/6)
  45. 7. Licensing Issues in Nanotechnology (3/6)
  46. 7. Licensing Issues in Nanotechnology (4/6)
  47. 7. Licensing Issues in Nanotechnology (5/6)
  48. 7. Licensing Issues in Nanotechnology (6/6)
  49. 8. IP Valuation: Principles and Applications in the Nanotechnology Industry (1/4)
  50. 8. IP Valuation: Principles and Applications in the Nanotechnology Industry (2/4)
  51. 8. IP Valuation: Principles and Applications in the Nanotechnology Industry (3/4)
  52. 8. IP Valuation: Principles and Applications in the Nanotechnology Industry (4/4)
  53. 9. Investing in Nanotechnology (1/7)
  54. 9. Investing in Nanotechnology (2/7)
  55. 9. Investing in Nanotechnology (3/7)
  56. 9. Investing in Nanotechnology (4/7)
  57. 9. Investing in Nanotechnology (5/7)
  58. 9. Investing in Nanotechnology (6/7)
  59. 9. Investing in Nanotechnology (7/7)
  60. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (1/6)
  61. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (2/6)
  62. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (3/6)
  63. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (4/6)
  64. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (5/6)
  65. 10. Technology Transfer and Nanomedicine with Special Reference to Sweden (6/6)
  66. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (1/6)
  67. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (2/6)
  68. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (3/6)
  69. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (4/6)
  70. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (5/6)
  71. 11. Public-Private Partnerships — an Example from the Netherlands: The Industrial Partnership Programme (6/6)
  72. 12. University and Employees’ Inventions in Europe and the United States (1/10)
  73. 12. University and Employees’ Inventions in Europe and the United States (2/10)
  74. 12. University and Employees’ Inventions in Europe and the United States (3/10)
  75. 12. University and Employees’ Inventions in Europe and the United States (4/10)
  76. 12. University and Employees’ Inventions in Europe and the United States (5/10)
  77. 12. University and Employees’ Inventions in Europe and the United States (6/10)
  78. 12. University and Employees’ Inventions in Europe and the United States (7/10)
  79. 12. University and Employees’ Inventions in Europe and the United States (8/10)
  80. 12. University and Employees’ Inventions in Europe and the United States (9/10)
  81. 12. University and Employees’ Inventions in Europe and the United States (10/10)
  82. 13. Environment, Health, and Safety Within the Nanotechnology Industry (1/4)
  83. 13. Environment, Health, and Safety Within the Nanotechnology Industry (2/4)
  84. 13. Environment, Health, and Safety Within the Nanotechnology Industry (3/4)
  85. 13. Environment, Health, and Safety Within the Nanotechnology Industry (4/4)
  86. 14. Regulation of Nanomaterials in the EU (1/4)
  87. 14. Regulation of Nanomaterials in the EU (2/4)
  88. 14. Regulation of Nanomaterials in the EU (3/4)
  89. 14. Regulation of Nanomaterials in the EU (4/4)
  90. 15. Nanomaterial Regulation in the United States (1/7)
  91. 15. Nanomaterial Regulation in the United States (2/7)
  92. 15. Nanomaterial Regulation in the United States (3/7)
  93. 15. Nanomaterial Regulation in the United States (4/7)
  94. 15. Nanomaterial Regulation in the United States (5/7)
  95. 15. Nanomaterial Regulation in the United States (6/7)
  96. 15. Nanomaterial Regulation in the United States (7/7)

Product information

  • Title: Nanotechnology Commercialization for Managers and Scientists
  • Author(s): Wim Helwegen, Luca Escoffier
  • Release date: February 2012
  • Publisher(s): Jenny Stanford Publishing
  • ISBN: 9789814364386